Covid-19: Serum Institute of India to get India nod soon after UK approval


Serum Institute of India may get emergency use approval for Covishield in India soon after the UK’s drug regulator MHRA gives a nod to the vaccine, which officials here expect to be before Christmas. The Medicines and Healthcare Products Regulatory Agency is currently evaluating data including which dosing regimen is best to use for the Covid vaccine developed by UK’s Oxford and AstraZeneca.